R R

What Is a Feinbloom Chart?

A Feinbloom chart is a low-vision testing tool that uses large numbers and symbols to measure visual acuity. The chart helps assess people who cannot read the standard Snellen chart. It uses high-contrast characters that remain visible at short distances. Many clinics rely on it to evaluate remaining sight in various conditions. Its flexibility makes it useful in both home and clinical settings.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is a Feinbloom Chart?

A Feinbloom chart is a low-vision testing tool that uses large numbers and symbols to measure visual acuity. The chart helps assess people who cannot read the standard Snellen chart. It uses high-contrast characters that remain visible at short distances. Many clinics rely on it to evaluate remaining sight in various conditions. Its flexibility makes it useful in both home and clinical settings.

read more about feinbloom chart ...

Copy this HTML:

Copy HTML Copied!

Why Do Doctors Use a Feinbloom Chart?

The chart helps measure vision when standard charts do not provide enough detail. It works well for people with significant vision loss. Doctors adjust working distance to find the clearest line. The tool helps create accurate acuity measurements despite severe blur. Results guide decisions on low-vision aids.

What Are Chart Features?

  • Large printed characters for high visibility.
  • Bold contrast for easier recognition.
  • Flexible testing distance.
  • Multiple size options on a single chart.

How Is the Chart Used in Testing?

Doctors place the chart at a comfortable viewing distance. Patients read the largest symbols first and move toward smaller ones. Each step helps estimate the remaining acuity. The test can be adapted for wheelchairs or limited mobility. The final measurement guides rehabilitation planning.

Feinbloom Chart Use in Low Vision Exams

A Feinbloom chart helps measure vision when standard letter charts are too hard to read. It uses large, high-contrast numbers and symbols and can be tested at flexible distances. Clinicians use the results to document remaining acuity and guide low-vision support, such as magnifiers or task lighting.

Frequently Asked Questions

Who benefits from a Feinbloom chart?

People with severe visual loss often use this chart. It provides clearer symbols at closer distances. Doctors choose it when standard charts are insufficient. It supports low-vision planning.

Can the chart be used at home?

Some people use portable versions for practice. Home use helps track changes. Doctors still review official measurements. Home results guide future visits.

How does it compare to a Snellen chart?

A Feinbloom chart works at flexible distances. It uses larger characters suited for low vision. Snellen charts rely on fixed spacing. Each tool serves different needs.

What conditions require Feinbloom testing?

Conditions like macular degeneration or advanced retinal disease may require it. The chart helps measure remaining sight accurately. Doctors use results to plan visual aids. Regular testing helps track changes.

References

Low Vision Rehabilitation: An Update. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC6010602/. Date Accessed March 20, 2026.

Comparing LEA Numbers Low Vision Book and Feinbloom Visual Acuity Charts. PubMed. https://pubmed.ncbi.nlm.nih.gov/23026789/. Date Accessed March 20, 2026.

Low Vision Device Requirements Among Children from Two Local Schools for the Blind in Tamil Nadu. PubMed. https://pubmed.ncbi.nlm.nih.gov/33323596/. Date Accessed March 20, 2026.

A Study of Eccentric Viewing Training for Low Vision Rehabilitation in Patients with Macular Disease. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3223708/. Date Accessed March 20, 2026.

Baseline Traits of Low Vision Patients Served by Private Outpatient Clinical Centers in the United States. JAMA Ophthalmology. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/1309590. Date Accessed March 20, 2026.